Cargando…
Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
GOAL: Combinatorial therapy directed at both vascular and neurodegenerative aspects of dementia may offer a promising strategy for treatment of dementia, which often has a multifactorial basis in the elderly. We investigated whether the phosphodiesterase III inhibitor cilostazol, which is often used...
Autores principales: | Ihara, Masafumi, Nishino, Madoka, Taguchi, Akihiko, Yamamoto, Yumi, Hattori, Yorito, Saito, Satoshi, Takahashi, Yukako, Tsuji, Masahiro, Kasahara, Yukiko, Takata, Yu, Okada, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935872/ https://www.ncbi.nlm.nih.gov/pubmed/24586841 http://dx.doi.org/10.1371/journal.pone.0089516 |
Ejemplares similares
-
Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome
por: Tsuji, Masahiro, et al.
Publicado: (2020) -
Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial
por: Saito, Satoshi, et al.
Publicado: (2023) -
Conversion from cilostazol to OPC‐13015 linked to mitigation of cognitive impairment
por: Saito, Satoshi, et al.
Publicado: (2021) -
Mild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurity
por: Ohshima, Makiko, et al.
Publicado: (2016) -
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia
por: Hattori, Yorito, et al.
Publicado: (2023)